In the past two years, studies have reported that lncRNA DUXAP8 promoted the proliferation and invasion of renal cell carcinoma [12], esophageal squamous cell carcinoma [13], gastric cancer [14], non-small cell lung cancer [15], and other tumors. Here, DUXAP8 is linked to hereditary clear cell renal cell carcinoma.